Pagina 2 - I migliori medici per il trattamento di Cancro gastrico stadio 2 - TOP-80 medici

La professoressa Yesim Yildirim è specializzata nell'immunoterapia oncologica e nelle terapie mirate, con oltre 80 pubblicazioni e collaborazioni in qualità di co-autrice in importanti manuali di oncologia.

• Membro della Società Europea di Oncologia Medica (ESMO)
• Professoressa presso l'Università di Halic, Istanbul
• Esperienza approfondita nei tumori gastrointestinali
• Ha completato una formazione avanzata nel Regno Unito e in Israele

Dr. Rahib Hasanov is a medical oncologist. He graduated from Istanbul University Cerrahpaşa Faculty of Medicine (1999–2005). He completed an internal medicine residency (2009–2013) and a medical oncology fellowship at Marmara University (2015–2018). He also completed an observership at Houston Methodist Hospital (2006–2007).

He focuses on personalized oncology. His treatments include immunotherapy, targeted therapy, and novel agents. His clinical interests include gastrointestinal, breast, lung, and genitourinary cancers.

He attends national and international conferences. He welcomes patients from Turkey, Azerbaijan, Montenegro, Georgia, Uzbekistan, the Middle East, Europe, and the United States.

Il Dr. Wolf dirige la Divisione di Oncologia Medica presso il Centro Medico Sourasky, un importante ospedale universitario israeliano con alta competenza nella cura del cancro complesso.

• Specializzato in oncologia medica e medicina interna
• Fluente in inglese per pazienti internazionali
• Ha conseguito una laurea presso l'Università Ben Gurion
• Ha acquisito vasta esperienza clinica nelle Unità Mediche dell'Esercito

Alla guida dell'Iniziativa Nazionale Israeliana di Medicina Genomica – il Dr. Raphael è specializzato nel profilo genomico avanzato per il trattamento personalizzato del cancro allo stomaco presso il Sourasky Medical Center.

• Docente Anziano in Oncologia Medica con un'ampia esperienza nella conduzione di trial clinici
• Esperto in biopsie liquide e profilazione genomica completa
• Investigatore Principale per numerosi studi innovativi su immunoterapia e chemioterapia
• Membro di ESMO, IASLC e altre prestigiose società oncologiche
• Vincitore di numerosi premi per l'eccellenza didattica e alla ricerca

Prof. Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital. He specializes in gastrointestinal and breast cancers. He has contributed to cancer care through research, especially with his study on the best timing for surgery after neoadjuvant therapy in rectal cancer. This work has influenced global treatment protocols.

Dr. Sağlam has led clinical trials in targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma was nominated for the 2024 International Best Researcher Award. He is a member of ASCO, ESMO, and ENET. Dr. Sağlam provides personalized and evidence-based oncology care.

Dr. Domenico Sabia is an experienced surgeon. He specializes in peritoneal oncology, melanoma and sarcoma surgery, laparoscopic and robotic surgery, and hepato-biliary and pancreatic surgery. He practices at Centro Médico Teknon and Consorci Sanitari Integral in Spain. Dr. Sabia has over 15 years of experience in treating advanced abdominal and pelvic cancers.

Dr. Sabia often speaks at national and international congresses. He has written and co-written many scientific publications. He also works as an investigator in major clinical trials in oncological surgery. He is accredited by organizations such as the Asociación Española de Cirujanos and The Peritoneal Surface Oncology Group International. Dr. Sabia is also a member of several respected surgical societies.

Dr. Irina Stepfansky is an oncologist and internal medicine specialist at Sourasky Medical Center. She has more than 25 years of clinical experience. Since 2015, she has directed the Oncology Hospitalization department. Dr. Stepfansky earned her medical degree from Grodno University in Belarus. She completed advanced oncology training at Tel Aviv Medical Center.

Dr. Stepfansky has been licensed in Israel since 2000. She has led and participated in many phase I-III oncology clinical trials. Her work has helped improve cancer care and patient outcomes. She is recognized for her expertise in both internal medicine and oncology. Dr. Stepfansky has a strong record in research and clinical leadership.

Il Prof. Oldhafer è specializzato in interventi chirurgici complessi su cancro al fegato e allo stomaco presso l'Ospedale Asklepios Barmbek, utilizzando tecniche avanzate come la chirurgia assistita da computer e la chirurgia mini-invasiva.

• Consulente senior di Chirurgia Generale e Addominale presso il Centro Medico Addominale
• Dirige un Centro per Malattie Epatobiliari gestendo casi complicati
• Utilizza la chirurgia epatica assistita da computer per la massima precisione
• Lavora con team multidisciplinari tra cui oncologia e radiologia

La Prof.ssa Elke Jaeger è una delle principali specialiste in sarcomi e una delle migliori oncologhe tedesche secondo la classifica di Focus.

• Responsabile di Oncologia ed Ematologia presso la Clinica Nordwest
• Oltre 35 anni di esperienza nella pratica oncologica
• Specializzata in tumori gastrointestinali complessi

Education and Expertise

Selcuk University Meram Faculty of Medicine - Medical Education

Dr.Abdurrahman Yurtaslan Anakara Oncology Training and Research Hospital Medical Oncology Specialization

Experience

Malatya State Hospital Internal Diseases Clinic

Ankara Oncology Hospital Medical Oncology Clinic

Erzurum Regional Training and Research Hospital Medical Oncology Clinic


AREAS OF INTEREST

Lung cancer

esophageal cancer

Gastric cancer

breast cancer

Gastrointestinal surgery

https://scholar.google.com.tr/citations?user=EDuylhoAAAAJ&hl=tr 

Oltre 40 anni a plasmare l'oncologia a livello globale – Il Prof. Zielinski guida la terapia personalizzata per il cancro presso il Centro Internazionale di Oncologia della Wiener Privatklinik.

• Fondatore e direttore del Comprehensive Cancer Center di Vienna
• Presidente del Central European Cooperative Oncology Group
• Pioniere nell'immunoterapia oncologica e nei trattamenti personalizzati
• Pubblicato ampiamente nelle principali riviste di oncologia

Dr. Saban Sec is a medical oncologist with experience at leading hospitals, including Haseki Training and Research Hospital, Prof. Dr. Cemil Taşcıoğlu City Hospital, and Bahçelievler Medikalpark Hospital. He currently represents specialist physicians in the Turkish Medical Oncology Association. He is also a member of the Istanbul Medical Chamber and the Turkish Medical Oncology Association.

Dr. Sec treats breast, lung, gastrointestinal, prostate, urogenital, head and neck cancers, as well as sarcomas and rare tumors. He has published many peer-reviewed articles on cancer prognosis, treatment outcomes, and survival rates. His research includes studies with large patient groups, such as 138 patients with HER2-positive metastatic gastric cancer. Dr. Sec focuses on prognostic factors and treatment responses in different cancers. He is dedicated to improving cancer care.

Senior surgeon of the “Gastrointestinal Medicine: General and Abdominal Surgery – Gastroenterology and Endoscopy” Department

Univ.-Prof. Dr. Wolfgang Johannes Köstler is a board-certified specialist for Internal Medicine, Hematology/Oncology, and Intensive Care Medicine who specializes in hematology & internal oncology, intensive care medicine. He is one of the top-rated breast cancer and sarcoma oncologist specialists and has extensive experience in the field and has received degrees from the Medical University of Vienna and the Weizmann Institute of Science. He has also had special training at Memorial Sloan-Kettering Cancer Center and Royal Prince Alfred Hospital.

Il Dott. Fox è specializzato nel trattamento del cancro allo stomaco, combinando chemioterapia, immunoterapia e terapie mirate per una cura personalizzata presso il Medical Center di Solingen.

• Ematologo, oncologo e immunologo certificato con oltre 15 anni di esperienza
• Primario presso un centro oncologico interdisciplinare certificato
• Esperto in diagnostica molecolare e approcci terapeutici innovativi
• Membro attivo di società di ricerca sul cancro tedesche e americane